Mutual funds ramp up stakes in 13 smallcap stocks that have surged up to 170% in FY26, with five turning multibaggers.Read More

Tata Capital is focusing on growth and customer affordability. The company is passing on lower funding costs to customers. Credit costs are declining and expected to go below 1% ahead of schedule. A 23-25% annual growth outlook remains intact. Operating efficiency and GenAI will drive profitability. Return on assets is projected to improve.Read More

Copper prices have stalled in early 2026 after a stellar 62% rally last year, with profit booking and volatility capping gains. While near-term momentum has softened, analysts say strong fundamentals and supply constraints continue to support the medium-term outlook.Read More

ITC Hotels posted strong Q3FY26 results, with net profit surging 77% year-on-year to Rs 235 crore and revenue rising 47%, driven by robust hotel demand, sequential growth, and the first real estate revenue contribution, despite higher costs and stock reaction.Read More

Post ContentRead More

Indian markets remain range-bound below 26,000, but key support at 25,450 could trigger a rebound, says Gautam Shah, Founder of Goldilocks Global Research. PSU banks and metals offer better risk-reward amid fair valuations, while FMCG and IT stocks remain expensive. Selective, concentrated investing is key as markets await budget-led triggers.Read More

Global markets tumbled Tuesday as U.S. futures indicated sharp declines following President Trump’s threat of new tariffs on eight European countries. Asian shares mostly fell, with Tokyo’s Nikkei down 1.1% amid election speculation and rising bond yields. European markets also opened lower, reflecting concerns over trade tensions and corporate earnings.Read More

Bajaj Electricals is venturing into the wires segment, boosting its stock by 11%. This strategic move aims to capitalize on rising demand and diversify operations. While existing players like RR Kabel and Havells saw dips, experts highlight the segment’s resilience and consistent growth, even with fluctuating copper prices. The company plans a phased investment based...Read More

Dr Reddy’s Laboratories anticipates a subdued performance for the December quarter. Pressure from its United States business is expected to offset steady growth in India and Europe. Analysts predict a decline in revenue and profit after tax. The US market faces challenges from pricing pressure and reduced contribution from gRevlimid.Read More

Bitcoin slipped to the $91,000 level amid risk-off sentiment triggered by escalating US–EU trade tensions. Broader crypto markets remained subdued as liquidations flushed out leverage, while analysts noted continued consolidation within a wide range, with macro cues and policy signals likely to drive the next directional move.Read More